Unknown

Dataset Information

0

Cost of whole genome sequencing for non-typhoidal Salmonella enterica.


ABSTRACT:

Background

While whole genome sequencing (WGS) may be more expensive than traditional testing and polymerase chain reaction (PCR), simple cost comparisons ignore the potential for WGS to reduce the societal costs of non-typhoidal Salmonella enterica through public health action to prevent illness.

Methods

We determined how many cases the use of WGS data would need to prevent to be cost-equal to serotyping and MLVA, or culture independent testing based on PCR in Australia. We then examined the costs and cost-savings of current typing methods compared with WGS in outbreak scenarios.

Results

A median of 275 (90% CrI -55-775) or 1.9% (90% CrI -0.4%-5.4%) of notified serotyped Salmonella cases would need to be prevented for WGS to be cost-equal to current typing methods and 1,550 (90% CrI 820-2,725) or 9.6% of all notified Salmonella cases would need to be prevented to be cost-equal to PCR. WGS is likely to result in cost savings in prolonged outbreaks, where data can support earlier public health action.

Conclusions

Despite currently having a higher cost per isolate, routine WGS of Salmonella was no more expensive than existing typing methods or PCR where >2% of illness was averted.

SUBMITTER: Ford L 

PROVIDER: S-EPMC7978342 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cost of whole genome sequencing for non-typhoidal Salmonella enterica.

Ford Laura L   Glass Kathryn K   Williamson Deborah A DA   Sintchenko Vitali V   Robson Jennifer M B JMB   Lancsar Emily E   Stafford Russell R   Kirk Martyn D MD  

PloS one 20210319 3


<h4>Background</h4>While whole genome sequencing (WGS) may be more expensive than traditional testing and polymerase chain reaction (PCR), simple cost comparisons ignore the potential for WGS to reduce the societal costs of non-typhoidal Salmonella enterica through public health action to prevent illness.<h4>Methods</h4>We determined how many cases the use of WGS data would need to prevent to be cost-equal to serotyping and MLVA, or culture independent testing based on PCR in Australia. We then  ...[more]

Similar Datasets

| S-EPMC5697165 | biostudies-literature
| S-EPMC5880904 | biostudies-literature
| S-EPMC4722277 | biostudies-literature
| S-EPMC4111163 | biostudies-literature
| S-EPMC3913712 | biostudies-literature
| S-EPMC7643971 | biostudies-literature
| S-EPMC10669045 | biostudies-literature
| S-EPMC3828162 | biostudies-literature
| S-EPMC11484373 | biostudies-literature
| S-EPMC8244875 | biostudies-literature